First Trust Advisors LP Moderna, Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Moderna, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 636,822 shares of MRNA stock, worth $25.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

636,822

Previous 508,832 25.15%

Holding current value

$25.1 Million

Previous $60.4 Million 29.57%

% of portfolio

0.04%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $8.15 Million - $16 Million	127,990 Added 25.15%	636,822 $42.6 Million
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $9.67 Million - $15.9 Million	-95,514 Reduced 15.8%	508,832 $60.4 Million
Q1 2024 May 13, 2024	SELL	$85.37 - $115.44 $24.7 Million - $33.4 Million	-288,970 Reduced 32.35%	604,346 $64.4 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $7.11 Million - $10.7 Million	102,251 Added 12.93%	893,316 $88.8 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $3.84 Million - $5.04 Million	39,807 Added 5.3%	791,065 $81.7 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $9.77 Million - $13.2 Million	82,476 Added 12.33%	751,258 $91.3 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $17.8 Million - $25.8 Million	-130,909 Reduced 16.37%	668,782 $103 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $20.4 Million - $36.3 Million	172,731 Added 27.55%	799,691 $144 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $14.4 Million - $23.7 Million	122,146 Added 24.2%	626,960 $74.1 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $288,022 - $434,234	-2,459 Reduced 0.48%	504,814 $72.1 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $18 Million - $33.4 Million	142,297 Added 38.99%	507,273 $87.4 Million
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $25.9 Million - $42.2 Million	-114,511 Reduced 23.88%	364,976 $92.7 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $62.7 Million - $137 Million	-282,557 Reduced 37.08%	479,487 $185 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $29.5 Million - $53.4 Million	227,063 Added 42.44%	762,044 $179 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $14.5 Million - $24.7 Million	132,798 Added 33.02%	534,981 $70.1 Million
Q4 2020 Feb 02, 2021	BUY	$65.74 - $169.86 $2.66 Million - $6.87 Million	40,468 Added 11.19%	402,183 $42 Million
Q3 2020 Nov 05, 2020	SELL	$54.34 - $94.85 $2.24 Million - $3.91 Million	-41,219 Reduced 10.23%	361,715 $25.6 Million
Q2 2020 Jul 22, 2020	SELL	$29.67 - $80.0 $1.07 Million - $2.88 Million	-36,012 Reduced 8.2%	402,934 $25.9 Million
Q1 2020 May 06, 2020	BUY	$17.78 - $31.58 $7.8 Million - $13.9 Million	438,946 New	438,946 $13.1 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Moderna, Inc. Transaction History